
Desnri 100mg Tablet ER
Marketer
Lupichem Healthcare
Salt Composition
Desvenlafaxine (100mg)
Overview Desnri 100mg Tablet ER
Deprenix 100mg Extended-Release tablets are a prescription medication for depression. This medication works by boosting brain levels of serotonin and norepinephrine, neurotransmitters that promote calmness and nerve relaxation, thereby alleviating depressive symptoms. Deprenix 100mg ER tablets are administered orally, with or without food, at the same time daily to ensure consistent blood levels. If a dose is missed, take it as soon as remembered; however, do not double up on doses. Complete the entire prescribed course, even if feeling improved. Abruptly stopping this medication without consulting your physician can worsen symptoms. Common side effects include nausea, vomiting, sleep disturbances (insomnia), and constipation. Blood pressure may rise, particularly during the first month; regular monitoring is recommended. Dizziness and drowsiness may occur; avoid driving or activities requiring alertness until the medication's effects are known. Report any unusual mood changes immediately to your doctor, as they may indicate suicidal ideation.
Primary Ingredients of Desnri 100mg Tablet ER
No information provided. Please provide the text you wish to be rephrased.
Uses of Desnri 100mg Tablet ER
Major Depressive Disorder
Major Benefits of Desnri 100mg Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Desnri 100mg Extended-Release tablets can be administered with or without food, although consistent timing is recommended.
Common Side effects of Desnri 100mg Tablet ER:
- Anxiety
- Constipation
- Decreased appetite
- Dizziness
- Increased sweating
- Insomnia (difficulty in sleeping)
- Nausea
- Sexual dysfunction
- Vomiting
How to use Desnri 100mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Desnri 100mg Extended-Release tablets can be consumed with or without food, although consistent timing is recommended.
How Desnri 100mg Tablet ER works:
Desnri 100mg Extended-Release tablets function by elevating brain levels of serotonin and noradrenaline, neurotransmitters crucial for preserving cognitive equilibrium.
SAFETY ADVICE
AlcoholCAUTION
Use caution when combining Desnri 100mg Extended-Release Tablets with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Extended-release Desnri 100mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Desnri 100mg tablet is likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking a Desnri 100mg extended-release tablet might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Exercise caution when prescribing Desnri 100mg Extended-Release tablets to individuals with impaired renal function. Dosage modification of Desnri 100mg Extended-Release tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Exercise caution when prescribing Desnri 100mg Extended-Release tablets to patients with hepatic impairment; dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Desnri 100mg Tablet ER :
Should you forget to take a Desnri 100mg Extended-Release Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Desnri 100mg Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Cyclohexanol Derivatives |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
